Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
State Street Materials Select Sector SPDR ETF
XLB
$8.87B
| $5.9M | 0.01% |
+116,013
| New | +$5.95M |
|
1252
Regeneron Pharmaceuticals
REGN
$85.9B
| $5.88M | 0.01% |
9,432
+7,927
| +527% | +$5.4M |
|
1253
CALL
Blackrock
BLK
$179B
| $5.87M | 0.01% |
6,100
+4,700
| +336% | +$4.86M |
|
1254
Philip Morris
PM
$293B
| $5.85M | 0.01% |
32,339
-20,854
| -39% | -$3.62M |
|
|
VGNT
1255
Versigent PLC
VGNT
$3.49B
| $5.85M | 0.01% |
+139,174
| New | +$5.55M |
|
1256
Benchmark Electronics
BHE
$2.61B
| $5.78M | 0.01% |
+58,578
| New | +$4.67M |
|
1257
PUT
MongoDB
MDB
$34.7B
| $5.78M | 0.01% |
17,200
-11,400
| -40% | -$3.42M |
|
1258
CALL
NXP Semiconductors
NXPI
$56.9B
| $5.76M | 0.01% |
20,500
+10,300
| +101% | +$2.84M |
|
1259
Royal Caribbean
RCL
$78.1B
| $5.74M | 0.01% |
18,074
-471,005
| -96% | -$132M |
|
1260
CALL
JetBlue
JBLU
$1.85B
| $5.73M | 0.01% |
1,000,000
-3,700,000
| -79% | -$18.8M |
|
1261
Virtu Financial
VIRT
$6B
| $5.73M | 0.01% |
96,135
-973,963
| -91% | -$51.2M |
|
1262
State Street Health Care Select Sector SPDR ETF
XLV
$45.5B
| $5.69M | 0.01% |
+35,892
| New | +$5.34M |
|
|
SNDK
1263
CALL
Sandisk
SNDK
$234B
| $5.68M | 0.01% |
2,500
+1,100
| +79% | +$1.57M |
|
|
JATT
1264
JATT II Acquisition Corp
JATT
$103M
| $5.68M | 0.01% |
+500,000
| New | +$5.31M |
|
1265
PUT
Suncor Energy
SU
$80B
| $5.64M | 0.01% |
105,100
| – | – |
|
1266
Mueller Industries
MLI
$14B
| $5.62M | 0.01% |
+91,378
| New | +$5.99M |
|
|
1267
PUT
Regeneron Pharmaceuticals
REGN
$85.9B
| $5.61M | 0.01% |
9,000
+8,000
| +800% | +$5.45M |
|
1268
Gildan
GIL
$10.4B
| $5.61M | 0.01% |
108,750
-129,942
| -54% | -$7.46M |
|
|
LAC
1269
Lithium Americas
LAC
$1.14B
| $5.56M | 0.01% |
1,445,418
-382,669
| -21% | -$1.82M |
|
|
HONA
1270
Honeywell Aerospace
HONA
$52.2B
| $5.56M | 0.01% |
+25,136
| New | +$5.55M |
|
1271
PUT
Virgin Galactic
SPCE
$467M
| $5.55M | 0.01% |
+1,920,000
| New | +$6.27M |
|
|
CRCL
1272
CALL
Circle Internet Group
CRCL
$22.3B
| $5.54M | 0.01% |
88,400
+27,700
| +46% | +$2.7M |
|
|
ARXS
1273
Arxis Inc
ARXS
$22.9B
| $5.53M | 0.01% |
+119,959
| New | +$4.68M |
|
1274
CALL
State Street Communication Services Select Sector SPDR ETF
XLC
$22.5B
| $5.53M | 0.01% |
+51,600
| New | +$5.88M |
|
1275
Mueller Water Products
MWA
$3.89B
| $5.52M | 0.01% |
213,711
-1,094,923
| -84% | -$29.3M |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.